Today: 14.Nov.2018
Molybdenum 99 Production for Nuclear Medicine 2010 - 2020 Europe
17.Mar.2015
Rate this item
(0 votes)

AIPES - The radionuclides supply for nuclear medicine is crucially dependent on an unsustainably low number of production reactors and processing facilities in Europe, North America, South-Africa and Asia/Pacific.

Read 1999 times Last modified on Thursday, 04 January 2018 17:02

Newsletter Subscription

  • Latest
  • Popular
  • Vijay Jayaraj, M.Sc. Environmental Science. Research Associate…
  • Vijay Jayaraj, M.Sc. Environmental Science. Research Associate…
  • Vijay Jayaraj, M.Sc. Environmental Science. Research Associate…
  • Melissa Goh, writer for CNBC: Nuclear power…
  • Michael Shellenberger, Environmental Progress: Let’s look at…